Image

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

Testing GIGA-2339 for safety in chronic Hepatitis B patients.

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing a new medicine called GIGA-2339 for people with chronic Hepatitis B Virus (HBV) infection. Hepatitis B is a virus that can infect the liver and cause long-term illness.

Participants will receive GIGA-2339 through an intravenous (IV) method, meaning the medicine is given through a vein. The study aims to check if the medicine is safe and how it behaves in the body. To join, participants need to have had Hepatitis B for at least 6 months and be on stable treatment already.

People with certain conditions, like other liver diseases or infections like Hepatitis C or HIV, can't join. Also, pregnant or breastfeeding women, and men who don't agree to use birth control methods, are not eligible. The study may have some risks, so it's important to discuss with a doctor.

  • Participants will receive GIGA-2339 through IV.
  • The study checks how safe the medicine is and how it acts in the body.
  • Eligibility includes having Hepatitis B for at least 6 months and no other serious health issues.
Print
Study details
    Hepatitis B Virus Infection

NCT07024641

GigaGen, Inc.

23 August 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.